Caina Technology Co

Caina Technology Co Equity Ratio

The Equity Ratio of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 91.68 %. In the previous year, Equity Ratio was 91.42 % — a change of 0.29% (higher).

Equity Ratio

91.68 %

YoY

0.29%

Last updated:

Equity Ratio of Caina Technology Co is 2025 91.68 % . Equity Ratio of Caina Technology Co was 2024 91.42 % . It decreases by 0.29% higher compared to the previous year.

The Caina Technology Co Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
41.60 CNY
Jan 1, 2019
60.68 CNY
Jan 1, 2020
79.76 CNY
Jan 1, 2021
83.27 CNY
Jan 1, 2022
94.19 CNY
Jan 1, 2023
93.65 CNY
Jan 1, 2024
91.42 CNY
Jan 1, 2025
91.68 CNY
The Caina Technology Co Equity Ratio history
YEAREquity RatioYoY
91.68 %+0.29%
91.42 %-2.38%
93.65 %-0.58%
94.19 %+13.12%
83.27 %+4.40%
79.76 %+31.44%
60.68 %+45.85%
41.60 %-7.00%
44.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Equity Ratio of Caina Technology Co is 91.68 % in 2025.

Equity Ratio of Caina Technology Co changed from 91.42 % to 91.68 %, representing a 0.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Caina Technology Co

All Key Metrics — Caina Technology Co